PFE28.41+1.2%
MRK104.22-0.4%
LLY812.05+2.1%
NVS117.88+0.6%
AZN76.30-0.8%
BMY51.14+0.3%
VRTX468.92+1.7%
GILD84.27-0.2%
REGN1,012.55+0.9%
BIIB234.10-1.1%
PFE28.41+1.2%
MRK104.22-0.4%
LLY812.05+2.1%
NVS117.88+0.6%
AZN76.30-0.8%
BMY51.14+0.3%
VRTX468.92+1.7%
GILD84.27-0.2%
REGN1,012.55+0.9%
BIIB234.10-1.1%
Condor-grade finance × SiteGrades-grade performance

The pharma-finance
command center
built for trial sites.

Recruitment activity becomes revenue. Revenue becomes forecast. Forecast becomes board decisions. Decisions reveal contracting gaps. Pharma Watcher closes them. One closed loop.

$1.6M
90-day forecast
$318K
Invoice-ready
$60K
AR at risk
27%
TA coverage
Live Alerts
4 active
ONCO-241 enrollment 6 patients behind plan — sub-I capacity flagged.
12m ago
3 invoices crossed 60-day AR bucket — $42.8K at risk.
1h ago
PF-2255 advanced to Phase III in Immunology — fit score 84.
3h ago
CARDIO-118 screening conversion dropped to 58% (−9pt WoW).
5h ago
Product · live preview

Three surfaces. One financial command center.

Executive metrics, finance ledger, and Pharma Watcher intel — wired together so every recruitment dollar moves the next opportunity forward.
Layer 03 · Decision
Executive Dashboard
LIVE
90-Day rev
$1.61M
+6.2%
Inv-Ready
$318K
82 ev
AR @ Risk
$60.4K
60+ d
Contracting
358
gap
Pipeline Cov
27%
of TA
Revenue · 8w trailing
Today's brief
  • ONCO-241 top Q4 contributor
  • 3 invoices crossed 60d AR
  • Pipeline cov 27% · gap closable
Layer 02 · Finance
Finance Command Center
SYNCED
CRIO Upload· q4-revenue-export.csv parsed · 1,284 rows
Revenue Forecast · Q1–Q4
actualforecast
AR Aging
0–30 d$192K
31–60 d$78K
61–90 d$36K
90+ d$24K
Invoice-Ready Events · 82
EventStudyAmountStatus
EV-4421ONCO-241$4,280ok
EV-4422CARDIO-118$1,820ok
EV-4423NEURO-077$4,400review
EV-4424DERM-302$980ok
Layer 04 · Intelligence
Pharma Watcher
STREAMING
OncologyCardioNeuroEndoImmunoPhase II → III · 38 moves · 30d
NCT05821744Ph III
Anti-PD-1 · NSCLC
Pfizer
92
NCT06104251Ph II
GLP-1 · T2DM
Eli Lilly
84
NCT05790187Ph II
Anti-IL23 · Crohn's
BMS
73
II→III
NCT05912034Ph III
JAKi · Atopic Derm
AbbVie
67
Rec.
Sponsor / CRO intel
Pfizer
184 active
+12%
Eli Lilly
152 active
+18%
How the loop closes

One feedback loop. Every screen is a step in it.

step 01
Upload CRIO report
layer 02 · finance
step 02
Validate site activity
layer 01 → 02
step 03
Convert to revenue events
layer 02
step 04
Forecast cash
layer 02 · 03
step 05
Identify invoice-ready work
layer 02
step 06
Track AR risk
layer 02
step 07
Detect contracting gap
layer 03
step 08
Find future studies
layer 04 · watcher
step 09
Feed back into forecast
layer 04 → 02
closed loop · every step instrumented
Integrations · placeholder cards

Dummy now. API-ready everywhere.

Every data source is wired through a contract so dummy data swaps to a live response with zero schema change. See the full list in Settings → Integrations.

future api
CRIO
future api
ClinicalTrials.gov
future api
openFDA
future api
Plaid
future api
QuickBooks
future api
Veeva/SiteVault
future api
NetSuite
future api
Sage
future api
Xero
View all →
TrialFinv0.1 · wireframe

The financial command center built for clinical trial sites. Recruitment → revenue → business development, in one terminal.

For Sites
  • Controllers
  • Recruitment Leads
  • CFO / COO
  • BD Officers
© 2025 TrialFin Inc. · All data shown is illustrative.Built for sites, not sponsors.

Made with Emergent